Tofacit XR is an extended-release tablet made by Delta Pharma Limited that contains tofacitinib 11 mg. It is an immunosuppressant prescribed for adults with certain inflammatory conditions, and it works by dampening specific immune signals in the body.
There are 13 brands of Tofacitinib listed in Bangladesh. 2 of them have a lower unit price than Tofacit XR. The lowest listed price is Tofacit 5 mg Tablet at ৳ 30.00 per unit.
What is Tofacit XR 11 mg Xr Tablet?
Tofacit XR is an extended-release tablet from Delta Pharma Limited containing tofacitinib 11 mg. Tofacitinib belongs to a group of medicines called immunosuppressants. It acts on certain signalling pathways inside immune cells, which reduces the body's response to inflammatory cytokine signals. In adults, it is used for moderately to severely active rheumatoid arthritis when methotrexate has not worked well enough or has not been tolerated. It may be given alone or together with methotrexate or other nonbiologic disease-modifying antirheumatic drugs. Because it affects immune function, it is used under close medical supervision, and the doctor decides whether it suits a particular person.
Uses of Tofacit XR
Tofacit XR is used in adults with moderately to severely active rheumatoid arthritis who have not responded adequately to methotrexate or who could not tolerate it. It can be taken on its own or alongside methotrexate or other nonbiologic disease-modifying antirheumatic drugs. It is an immunosuppressant medicine, so it is meant for people whose condition has been assessed by a doctor. It is not a painkiller for everyday aches, and it should not be started without a specialist's advice. Ask your doctor whether this medicine is appropriate for your type of arthritis.
How to use Tofacit XR
Tofacit XR is an extended-release tablet, so swallow it as your doctor directs; do not crush or chew it unless your doctor says otherwise. The doctor decides the dose and how long you take it, including any change for kidney or liver problems. Take it at the times your doctor sets, and do not stop or restart on your own. If you miss a dose or are unsure how to take it, ask your doctor or pharmacist rather than guessing. Tell your doctor about all other medicines you use, since some can interact with it.
Side effects of Tofacit XR
In clinical trials, the most commonly reported side effects during the first three months were upper respiratory tract infections, headache, diarrhoea and nasopharyngitis (a cold-like inflammation of the nose and throat). Because tofacitinib affects immune function, serious infections can occur, and the doctor may check blood counts and other tests during treatment. Call your doctor promptly if you develop fever, signs of infection, unusual tiredness, or ongoing diarrhoea, or if anything worries you. Do not treat new symptoms on your own; your doctor will advise what to do.
Safety and precautions
Tofacit XR should not be used during an active serious infection, including localized infections. It is used with caution in people who may be at higher risk of gastrointestinal perforation. The doctor usually arranges monitoring of lymphocytes, neutrophils, haemoglobin, liver enzymes and lipids. Live vaccines should be avoided while on this medicine. Treatment is not started if certain blood counts are below the doctor's limits. In pregnancy, it is used only if the benefit justifies the risk to the fetus, and breastfeeding decisions should be discussed with the doctor. Tell your doctor about infections, kidney or liver problems, pregnancy, planning pregnancy or breastfeeding before starting.
Frequently asked questions
What is Tofacit XR used for and what kind of medicine is it?
It is an immunosuppressant containing tofacitinib, used in adults with moderately to severely active rheumatoid arthritis after methotrexate has not worked well enough or was not tolerated. It may be given alone or with other disease-modifying antirheumatic drugs. Ask your doctor if it suits your condition.
What side effects should I watch for, and when should I call the doctor?
Common side effects reported early in treatment include upper respiratory tract infections, headache, diarrhoea and cold-like nose and throat symptoms. Call your doctor promptly if you have fever or signs of infection, unusual tiredness, ongoing diarrhoea, or any symptom that concerns you. Do not self-treat new symptoms.
How should Tofacit XR be taken?
Swallow the extended-release tablet as your doctor instructs, and do not crush or chew it unless told otherwise. The doctor decides the dose, any adjustment for kidney or liver problems, and how long you take it. Ask your doctor or pharmacist if you miss a dose or are unsure.
What is the price of Tofacit XR?
The listed price is ৳ 60.00. Ask your pharmacist about availability and any current pricing, as these can change.
Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic ... Read moreRheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).
Psoriatic Arthritis: Tofacitinib is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Ulcerative Colitis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
Pharmacology
Rheumatoid arthritis is an autoimmune disease characterized by a dysregulation of pro-inflammatory cytokines including IL7, IL15, IL21, IL6, IFN-alpha, and IFN-beta. (3) Cytokines signalling results in tissue inflammation and joint damage by stimulating the recruitment and activation of immune cells via the janus kinase signalling pathway.
Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. The JAK-STAT signalling pathway is involved in the transcription of cells involved in hematopoiesis, and immune cell function. Tofacitinib works therapeutically by inhibiting the JAK-STAT pathway to decrease the inflammatory response. However, there is evidence to suggest that it may also achieve efficacy via other pathways as well.
Dosage & Administration
Rheumatoid Arthritis: Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.
Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.
Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.
Interaction
Potent inhibitors of Cytochrome P450 3A4 (CYP3A4) (e.g., Ketoconazole)
Recommended dose is Tofacitinib 5 mg once daily: One or more concomitant medications that result in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)
Recommended dose is Tofacitinib 5 mg once daily Potent CYP inducers (e.g.Rifampin): May result in loss of or reduced clinical response.
Side Effects
The most commonly reported adverse reactions during the first 3 months in controlled clinical trials (occurring in greater than or equal to 2% of patients treated with Tofacitinib monotherapy or in combination with DMARDs) were upper respiratory tract infections, headache, diarrhea and nasopharyngitis.
Pregnancy & Lactation
Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. Tofacitinib should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is not known whether Tofacitinib is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Tofacitinib, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug for the mother
Precautions & Warnings
Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections.
Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.
Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
Immunizations: Live vaccines: Avoid use with Tofacitinib.
Do not initiate Tofacitinib if absolute lymphocyte count <500 cells/mm3, an absolute neutrophil count (ANC) <1000 cells/mm3 or hemoglobin <9 gm/dL.
Storage Conditions
Store below 30°C. Protect from light & moisture. Keep all medicines out of the reach of children.
Alternative brands of Tofacitinib
Other brands with the same generic name, cheapest first.